Science Explorer Back to mapMap
Discussion
Researcher · Belarusian Research Center For Pediatric Oncology and Hematology · Belarus

Marina V. Borisevich

Marina V. Borisevich publishes mostly in Hematology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Childhood Cancer Survivors' Quality of Life.

ORCID 0000-0002-5180-5584 OpenAlex
World rank
#3,185,339
of 7,710,434 ranked researchers
Rank in Belarus
#194
of 4,813
Works
20
Citations
170
Citations per work
8.5
h-index
5
i10-index 4Top 89% in Hematology
Marina V. Borisevich

What does Marina V. Borisevich research?

Marina V. Borisevich's work is mostly in Medicine (87%).

Health Sciences: 17 works · 86.8% of their workMedicine: 17 works · 86.8% of their workHematology: 5 works · 24.5% of their workPediatrics, Perinatology and Child Health: 4 works · 20.8% of their workPublic Health, Environmental and Occupational Health: 3 works · 15.1% of their workGenetics: 3 works · 13.2% of their workRheumatology: 2 works · 7.5% of their workPulmonary and Respiratory Medicine: 1 works · 5.7% of their workEverything else: 3 works · 13.2% of their workTHEIR WORKMarina V.Borisevich20works
Health Sciences87%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1786.8%
  2. Everything else313.2%
  1. 1Hematology24% of their works
  2. 2Pediatrics, Perinatology and Child Health21% of their works
  3. 3Public Health, Environmental and Occupational Health15% of their works
  4. 4Genetics13% of their works
  5. 5Rheumatology8% of their works
  6. 6Pulmonary and Respiratory Medicine6% of their works

Research topics

Which keywords describe Marina V. Borisevich's research?

The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations, Childhood Cancer Survivor Study, Pediatric Quality of Life Inventory and Acute Lymphoblastic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Prognostic Factors143 topics
  2. BCR-ABL111 topic
  3. Imatinib111 topic
  4. Chronic Lymphocytic Leukemia71 topic
  5. Genomic Aberrations71 topic
  6. Childhood Cancer Survivor Study61 topic
  7. Pediatric Quality of Life Inventory61 topic
  8. Acute Lymphoblastic Leukemia51 topic
  9. Childhood Cancer51 topic
  10. Fusion Genes41 topic
  11. Hypereosinophilic Syndrome41 topic
  12. End-of-Life31 topic
  13. Palliative Care31 topic
  14. AML21 topic
  15. Acute Myeloid Leukemia21 topic
  16. Medical Ethics21 topic
  17. Pediatric21 topic

Where does Marina V. Borisevich work?

Marina V. Borisevich's main affiliation in the publication record is Belarusian Research Center For Pediatric Oncology and Hematology, Belarus.

How many publications and citations does Marina V. Borisevich have?

OpenAlex counts 20 works and 170 citations for Marina V. Borisevich, an h-index of 5, ranking #3,185,339 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marina V. Borisevich. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.